Exosens Stock Breaks Key Resistance at 65.30 Euros, Up 43% in Three Months
Exosens continues its upward trend this Thursday, March 5, with a share price reaching 66.60 euros, up 2.78% from the previous day. The photon detection and amplification technology specialist's stock now shows a gain of nearly 12% over seven days and more than 43% over three months. This acceleration occurs amid geopolitical tensions in the Middle East and following a target price upgrade by an analyst earlier in the week.
On Monday, March 3, the research firm Bernstein raised its price target on Exosens from 61.00 euros to 72.50 euros, while maintaining its 'outperform' rating. At the current price of 66.60 euros, this new target represents a potential upside of approximately 8.9%. This upgrade comes as the company, listed on Euronext Paris since 2024, operates in the high-performance optoelectronics and sensors sector, with applications spanning defense, aerospace, and nuclear industries. The next financial milestone on the calendar is the publication of the first quarter 2026 results, expected on April 27, followed by the annual general meeting scheduled for May 22.
Technical Breakthrough in Today's Session
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
From a technical perspective, today's session marks a significant event: the share price of 66.60 euros has surpassed the identified resistance at 65.30 euros as well as the upper Bollinger band at 66.51 euros. This simultaneous breach signals an acceleration of the short-term bullish trend, although the distance of the stock from this band may also indicate a marked extension from its recent dynamics. Concurrently, the Relative Strength Index (RSI) stands at 72, a level indicating an overbought zone, meaning that buying pressure has been particularly strong in recent sessions. The stock is trading well above its 50-day moving average, set at 55.33 euros, and even more so above its 200-day average (45.95 euros), confirming the strength of the upward trend initiated in recent months. The annual performance now exceeds 111%, illustrating the continuous revaluation trajectory of the stock since its IPO.
Nous sommes fiers de présenter notre performance sur les neuf premiers mois de l’année 2025, qui témoignent d'une croissance soutenue du chiffre d'affaires et de la marge brute ajustée, portée par la forte dynamique du secteur de la Défense.
Marché de la Défense très dynamique, forte demande pour la vision nocturne et les systèmes pour drones/anti-drones, croissance soutenue en Europe avec contribution des États-Unis et de l’Asie-Pacifique. Lancement commercial réussi des tubes 5G (plus de 5 000 commandes avant lancement).
Risks mentioned
Cession de l’activité Amplification par Micro-ondes entraînant une perte comptable sans impact de trésorerie en 2025
Dépendance aux budgets de Défense et aux évolutions géopolitiques
Risque d'intégration des acquisitions récentes
Incertitudes de la demande dans les Sciences de la Vie (marché américain)
Opportunities identified
Croissance adressable liée à la vision nocturne et aux applications drones/anti-drones
Commercialisation des tubes 5G avec commandes significatives (>5 000 tubes)
Expansion des capacités de production (+40% d’ici 2027) soutenant le développement commercial
Effets de croissance externe (Noxant, NVLS, Phasics) élargissant le marché adressable
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
